https://www.avient.com/resources/safety-data-sheets?page=4338
030BK2031 BLACK
PA66 G25 H UF natural.
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=5388
AZUL "H" MB
BLACK TINT
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=3773
AC 1259-H 8900-267300-001
BLACK CO2 LM
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=3965
WHITE H CAP DR101
BLACK DYNA 2709
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=3355
Geon(TM) DB4942 Black Tex 85
PA66 G/MI40 H black VN4255CF LS
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=5214
H&S PREMIUM COLLETION
BLACK 923202 HIPS UV
PP FR 8-6 LMS-1000
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
Whether
an additional line at an existing
manufacturing plant, or a new
facility in a growing region, we
ramp-up quickly and cost-efficiently.
26
Capex / Revenue
2021E (%)
AV I E N T I S A SS E T L I G H T
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
2 3 2 2 2
3 3
4
3 3
4 4 4 5
5 5 5
6 7
8
23
A
vi
e
n
t
A
vi
e
n
t
(E
xc
l.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA
Median: 84% Median: 78%
H I G H F R E E C A S H F L OW
C O N V E R S I O N
Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M)
Source: Peer data per Bloomberg market data as of June 4, 2021
87
89 87 86
83 81
76
88 85 83 82 81 80 78 78 78 76
72 71 69
50
18
A
vi
e
n
t
K
W
R
P
P
G
R
P
M
A
V
Y
F
U
L
G
C
P
F
M
C
H
X
L
U
N
V
R
IF
F
E
C
L
A
S
H
F
O
E
C
E
E
M
N
B
N
R
H
U
N
G
R
A
K
R
A
S
C
L
A
L
B
Source: Peer data per Bloomberg market data as of June 4, 2021
Total Enterprise Value / 2021E EBITDA
Our current valuation with updated
guidance implies an EBITDA multiple
that is below specialty formulator
peers and the majority of our
chemical peers.
With the Clariant Masterbatch
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
28
Avient reflects 2021 estimated EBITDA of $560M
O U R VA LUATI O N V E R S U S P E E R S
Avient Specialty
Formulators
Other
Chemical/Specialty
Companies
10.4
18.2
16.0 15.5 15.3
11.3 11.0
29.7
26.5
23.5
18.2
13.4
11.9 11.9 11.7 10.5 10.4 10.3
10.1 9.7
7.7
6.5
A
vi
e
n
t
K
W
R
A
V
Y
P
P
G
R
P
M
F
U
L
G
C
P
H
X
L
A
L
B
E
C
L
IF
F
F
M
C
B
N
R
A
S
H
G
R
A
E
M
N
F
O
E
S
C
L
U
N
V
R
C
E
K
R
A
H
U
N
Median: 11.7xMedian: 15.4x
S U M M A RY: W H Y I N V E S T I N AV I E N T ?
https://www.avient.com/resources/safety-data-sheets?page=1484
XPPC HI H UV WHITE
KI BLACK
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=4126
GEON B7500 BLACK
V1466-70 WHITE
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=7024
70-BK-121 BLACK
RC BLACK AO
PP FR 8-6 LMS-1000